Bogart Wealth LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
-$28.2K 1430
2024
Q4
Hold
0
511

Other funds holding BMY

Bogart Wealth LLC's BMY Position: Q2 2026 in Review

Bogart Wealth LLC reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $2.3K and leaving 2,344 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #341.

Bogart Wealth LLC first reported a position in BMY in Q3 2017 and has held it in 36 quarters since. The position peaked at $6.18M in Q1 2024. 834 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Bogart Wealth LLC held 2,344 shares of Bristol-Myers Squibb worth $135K as of Q2 2026.
  • Bogart Wealth LLC sold 40 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.3K.
  • Bristol-Myers Squibb made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #341 holding.
  • Bogart Wealth LLC first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 36 quarters since.
  • Bogart Wealth LLC's Bristol-Myers Squibb position peaked at $6.18M in Q1 2024.
  • 834 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.